CD40LG and pulmonary fibrosis: We conducted further studies to explore whether CXXC5 exerted antifibrotic effects through the negative regulation of CD40/CD40L and found that CD40 and CD40L were upregulated in the pulmonary fibrosis model both in vitro and in vivo, but CD40 and CD40L were downregulated after CXXC5 overexpression.